ไฮดรอกซิซีน
เชิงอรรถและอ้างอิง

↑  "Drugs@FDA: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). สืบค้นเมื่อ 5 August 2020.
↑  Hubbard JR, Martin PR (2001). Substance Abuse in the Mentally and Physically Disabled. CRC Press. p. 26. ISBN 9780824744977.
↑  "Hydroxyzine". pubchem.ncbi.nlm.nih.gov. สืบค้นเมื่อ 4 March 2020.
1 2  Paton DM, Webster DR (1985). "Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines)". Clin. Pharmacokinet. 10 (6): 477–97. doi:10.2165/00003088-198510060-00002. PMID 2866055. S2CID 33541001.
↑  Simons FE, Simons KJ, Frith EM (1984). "The pharmacokinetics and antihistaminic of the H1 receptor antagonist hydroxyzine". J. Allergy Clin. Immunol. 73 (1 Pt 1): 69–75. doi:10.1016/0091-6749(84)90486-x. PMID 6141198.
↑  Simons KJ, Watson WT, Chen XY, Simons FE (January 1989). "Pharmacokinetic and pharmacodynamic studies of the H1-receptor antagonist hydroxyzine in the elderly". Clin Pharmacol Ther. 45 (1): 9–14. doi:10.1038/clpt.1989.2. PMID 2562944. S2CID 24571876.
↑  Shorter, Edward (2009). Before Prozac: the troubled history of mood disorders in psychiatry. Oxford [Oxfordshire]: Oxford University Press. ISBN 0-19-536874-6.
↑  SCHRAM, WS (March 1959). "Use of hydroxyzine in psychosis". Diseases of the Nervous System. 20 (3): 126–9. PMID 13639831.
↑  "HYDROXYZINE PAMOATE - hydroxyzine pamoate capsule (American Health Packaging)". NIH. สืบค้นเมื่อ 2017-02-06.
↑  
"Hydroxyzine Facts and Comparisons at Drugs.com".
↑  H. Morren, U.S. Patent 2,899,436 (1959) ; H. Morren, DE 1049383  (1954) ; H. Morren, DE 1061786  (1954) ; H. Morren, DE 1068262  (1954) ; H. Morren, DE 1072624  (1954) ; H. Morren, DE 1075116  (1954).
↑  Gillard M, Van Der Perren C, Moguilevsky N, Massingham R, Chatelain P (February 2002). "Binding characteristics of cetirizine and levocetirizine to human H(1) histamine receptors: contribution of Lys (191) and Thr (194)". Molecular Pharmacology. 61 (2): 391–9. doi:10.1124/mol.61.2.391. PMID 11809864.[ลิงก์เสีย]
1 2 3  
Snowman, AM; Snyder, SH (December 1990). "Cetirizine: actions on neurotransmitter receptors". The Journal of Allergy and Clinical Immunology. 86 (6 Pt 2): 1025–8. doi:10.1016/S0091-6749(05)80248-9. PMID 1979798.
1 2 3  
Kubo N, Shirakawa O, Kuno T, Tanaka C (March 1987). "Antimuscarinic effects of antihistamines: quantitative evaluation by receptor-binding assay". Japanese Journal of Pharmacology. 43 (3): 277–82. doi:10.1254/jjp.43.277. PMID 2884340.
1 2 3  
White RP, Boyajy LD (September 1960). "Neuropharmacological comparison of atropine, scopolamine, banactyzine, diphenhydramine and hydroxyzine". Archives Internationales de Pharmacodynamie et de Thérapie. 127: 260–73. PMID 13784865.
1 2  Haraguchi K, Ito K, Kotaki H, Sawada Y, Iga T (June 1997). "Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies". Drug Metabolism and Disposition: the Biological Fate of Chemicals. 25 (6): 675–84. PMID 9193868. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2021-08-28. สืบค้นเมื่อ 2017-02-06.
↑  
Orzechowski RF, Currie DS, Valancius CA (January 2005). "Comparative anticholinergic activities of 10 histamine H1 receptor antagonists in two functional models". European Journal of Pharmacology. 506 (3): 257–64. doi:10.1016/j.ejphar.2004.11.006. PMID 15627436.
↑  
Berger, F. M. (1957). "THE CHEMISTRY AND MODE OF ACTION OF TRANQUILIZING DRUGS". Annals of the New York Academy of Sciences. 67 (10): 685–700. doi:10.1111/j.1749-6632.1957.tb46006.x. ISSN 0077-8923.
↑  
Tripathi, KD (2013). Essentials of Medical Pharmacology. JP Medical Ltd. p. 165. ISBN 978-93-5025-937-5.
↑  Rothbaum, Barbara Olasov; Stein, Dan J; Hollander, Eric (2009). Textbook of Anxiety Disorders. American Psychiatric Publishing, Inc. ISBN 1-58562-254-0.
↑  Lamberty Y, Gower AJ (September 2004). "Hydroxyzine prevents isolation-induced vocalization in guinea pig pups: comparison with chlorpheniramine and immepip". Pharmacology, Biochemistry, and Behavior. 79 (1): 119–24. doi:10.1016/j.pbb.2004.06.015. PMID 15388291.
↑  Llorca PM, Spadone C, Sol O (November 2002). "Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study" (PDF). J Clin Psychiatry. 63 (11): 1020–7. doi:10.4088/JCP.v63n1112. PMID 12444816.
↑  Guaiana, Giuseppe; Barbui, Corrado; Cipriani, Andrea (2010-12-08). "Hydroxyzine for generalised anxiety disorder". The Cochrane Library. Cochrane Depression, Anxiety and Neurosis Group. doi:10.1002/14651858.CD006815.pub2.
↑  VISTARIL (hydroxyzine pamoate), pp. 1
↑  United States Food & Drug Administration, (2004), p1
1 2 3 4 5 6 7  VISTARIL (hydroxyzine pamoate), p. 2
1 2 3  Dolan, C. M. (June 1958). "MANAGEMENT OF EMOTIONAL DISTURBANCES—Use of Hydroxyzine (Atarax®) in General Practice". Calif Med. 88 (6): 443–444. PMC 1512309. PMID 13536863.
↑  Porsolt, Roger D; Martin, P; Lenégre, A; Fromage, S; Giurgea, CE (1989). "Prevention of "learned helplessness" in the rat by hydroxyzine". Drug Development Research. 17 (3): 227–236. doi:10.1002/ddr.430170306.
↑  "Ucerax (hydroxyzine hydrochloride) 25 mg film-coated tablets. Summary of product characteristics" (PDF). Irish Medicines Board. สืบค้นเมื่อ 2014-02-09.
↑  
"Vistaril". The extent of renal excretion of VISTARIL has not been determined
↑  "US Prescription Information - Vistaril" (PDF). คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 2007-07-03. สืบค้นเมื่อ 2017-02-06.
1 2 3  VISTARIL (hydroxyzine pamoate), p. 3
1 2 3  Clark, B. G.; M. Araki; H. W. Brown (1982). "Hydroxyzine-Associated Tardive Dyskinesia". Ann. Neurol. 11 (4): 435. doi:10.1002/ana.410110423. PMID 7103423.
↑  H Kenneth Walker, บ.ก. (1990). "70: Involuntary Movements". Clinical Methods: The History, Physical, and Laboratory Examinations (3rd ed.). Boston: Butterworths. PMID 21250235.
1 2 3  UCB South-Africa, et al., (2004)
↑  Anderson, Philip O.; James E. Knoben; William G. Troutman (2002). Handbook of Clinical Drug Data. McGraw-Hill Medical. pp. 794-796. ISBN 0-07-136362-9.
↑  de Brabander, A., Debert, W., (1990), p1
1 2  de Brabander, A., Debert, W., (1990), p3
↑  Alford C, Rombautt N, Jones J, Foley S, Idzikowskit C, Hindmarch I (January–February 1992). "Acute Effects of Hydroxyzine on Nocturnal Sleep and Sleep Tendency the Following Day: a C-EEG Study". Human Psychopharmacology. 7 (1): 25–35. doi:10.1002/hup.470070104. สืบค้นเมื่อ 2007-03-10.
↑  "NCQA's HEDIS Measure: Use of High Risk Medications in the Elderly" (PDF).
↑  "Unique Words". dictionary.reference.com.